Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet NAPHCON-A ophthalmic drops solution
- Product code:
- W02243001
- Quantity:
- 1
- Indicated for:
- allergic conjunctivitis; ocular irritation
- Route of administration:
- ophthalmic
- Substance:
- naphazoline + pheniramine maleate (alpha-adrenergic decongestant and H1 antihistamine)
- ATC
- S01GA51 — Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Anticholinergic effects
May cause dry mouth, constipation, urinary retention, or blurred vision.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Vision disturbances
This medicine may cause vision disturbances.
Naphazoline + pheniramine maleate is a combination used in eye drops for redness and itching associated with mild eye allergy. Naphazoline is a decongestant that narrows blood vessels in the eye and reduces redness, while pheniramine is an antihistamine that reduces allergic itching and watering.
It is used only in the eyes, according to the leaflet, for short periods. Wash hands before use and do not touch the bottle tip to the eye or skin. Contact lenses should be removed before administration and reinserted only as recommended in the leaflet. Prolonged or excessive use can cause rebound redness and worsening irritation.
Side effects may include stinging, burning, pupil dilation, blurred vision, dryness, headache, sleepiness or palpitations. Caution is advised in patients with narrow-angle glaucoma, high blood pressure, heart disease, diabetes, hyperthyroidism or treatment with MAO inhibitors. Do not use in children below the permitted age.
Consult a doctor urgently if eye pain, vision changes, severe light sensitivity, purulent discharge, eye injury, persistent redness or worsening after a few days occurs. Stop use if allergic reactions, severe dizziness or irregular heartbeat develops. The drops may relieve mild allergy symptoms, but they do not treat eye infections.
It is used only in the eyes, according to the leaflet, for short periods. Wash hands before use and do not touch the bottle tip to the eye or skin. Contact lenses should be removed before administration and reinserted only as recommended in the leaflet. Prolonged or excessive use can cause rebound redness and worsening irritation.
Side effects may include stinging, burning, pupil dilation, blurred vision, dryness, headache, sleepiness or palpitations. Caution is advised in patients with narrow-angle glaucoma, high blood pressure, heart disease, diabetes, hyperthyroidism or treatment with MAO inhibitors. Do not use in children below the permitted age.
Consult a doctor urgently if eye pain, vision changes, severe light sensitivity, purulent discharge, eye injury, persistent redness or worsening after a few days occurs. Stop use if allergic reactions, severe dizziness or irregular heartbeat develops. The drops may relieve mild allergy symptoms, but they do not treat eye infections.
General data about NAPHCON-A
- Substance:
- naphazoline + pheniramine maleate
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W02243001
- Pharmaceutical form:
- ophthalmic drops solution
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- OTC — Over the Counter = medicine that does not require a medical prescription.